Walleye Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Walleye Capital's CRL Position: Q3 2026 in Review
Walleye Capital opened a new position in Charles River Laboratories (CRL) in Q3 2026: 4,075 shares worth $1.2M. The stake represents ﹤0.01% of the portfolio and ranks #3290 among its holdings. This is a return to the name: Walleye Capital previously reported a position in CRL as recently as Q1 2026.
Walleye Capital first reported a position in CRL in Q1 2019 and has held it in 17 quarters since. The position peaked at $50.1M in Q4 2025. 639 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Walleye Capital held 4,075 shares of Charles River Laboratories worth $1.2M as of Q3 2026.
- Charles River Laboratories was a new Walleye Capital position in Q3 2026.
- Charles River Laboratories made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #3290 holding.
- Walleye Capital first reported a position in Charles River Laboratories in Q1 2019 and has held it in 17 quarters since.
- Walleye Capital's Charles River Laboratories position peaked at $50.1M in Q4 2025.
- 639 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.